Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer

PURPOSE: This phase I trial evaluated the question of whether the standard starting dose of axitinib could be administered in combination with therapeutic doses of cisplatin/capecitabine in patients with previously untreated advanced gastric cancer, and assessed overall safety, pharmacokinetics, and...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Res Treat
Glavni autori: Oh, Do-Youn, Doi, Toshihiko, Shirao, Kuniaki, Lee, Keun-Wook, Park, Sook Ryun, Chen, Ying, Yang, Liqiang, Valota, Olga, Bang, Yung-Jue
Format: Artigo
Jezik:Inglês
Izdano: Korean Cancer Association 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4614203/
https://ncbi.nlm.nih.gov/pubmed/25687867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.225
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items